Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
9.05
Nov 19 • 3:59 PM ET Dollar change-0.03 Percentage change(-0.33%)
Aftermarket Close
9.12
Aftermarket • 5:55 PM ET Dollar change+0.07 Percentage change(0.83%)
Index
-
Market Cap
39.72B
Enterprise Value
49.66B
Income
2.18B
Sales
14.97B
Book/sh
4.96
Cash/sh
0.25
Employees
-
IPO
Jul 18, 2022
P/E
18.61
Forward P/E
15.24
PEG
1.95
P/S
2.65
P/B
1.83
P/C
36.23
P/FCF
14.44
EV/EBITDA
12.54
EV/Sales
3.32
Quick Ratio
0.52
Current Ratio
0.69
Debt/Eq
0.50
LT Debt/Eq
0.38
Option/Short
Yes / Yes
EPS (ttm)
0.49
EPS next Y
0.59
EPS next Q
0.15
EPS this Y
9.64%
EPS next Y
6.44%
EPS next 5Y
7.82%
EPS past 3/5Y
20.04% 9.00%
Sales past 3/5Y
2.82% 2.76%
EPS Y/Y TTM
12.37%
Sales Y/Y TTM
4.99%
EPS Q/Q
24561.95%
Sales Q/Q
15.22%
Insider Own
0.00%
Insider Trans
-
Inst Own
16.14%
Inst Trans
-1.27%
ROA
5.02%
ROE
9.99%
ROIC
7.24%
Gross Margin
65.46%
Oper. Margin
23.31%
Profit Margin
14.55%
SMA20
-1.99%
SMA50
-2.89%
SMA200
-6.49%
Trades
Shs Outstand
4.39B
Shs Float
4.39B
52W High
11.28 -19.77%
52W Low
8.38 8.00%
Volatility
1.28% 1.87%
ATR (14)
0.21
RSI (14)
43.77
Beta
0.11
Rel Volume
0.70
Avg Volume
18.84M
Volume
13,251,473
Perf Week
-0.44%
Perf Month
-9.68%
Perf Quarter
-9.50%
Perf Half Y
-2.90%
Perf YTD
-10.48%
Perf Year
-4.84%
Perf 3Y
9.70%
Perf 5Y
-
Perf 10Y
-
Prev Close
9.08
Price
9.05
Change %
-0.33%
Consensus
Buy
Avg. Price Target
$10.21
Implied Upside
+12.8%
Analysts11incl. previous ratings
Rating Distribution6 Buy · 5 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Nov 04, 2026Downgrade
JEF logoJJefferies
Buy → Hold
Oct 30, 2026Upgrade
DB logoDDeutsche Bank
Sell → Hold
Jan 23, 2026Upgrade
BCS logoBBarclays
Equal Weight → Overweight
Sep 16, 2025Downgrade
BCS logoBBarclays
Overweight → Equal Weight
Sep 10, 2025Upgrade
GS logoGGoldman
Neutral → Buy
May 27, 2025Upgrade
BBNP Paribas Exane
Neutral → Outperform$13.40+48.1%
May 09, 2025Upgrade
MS logoMMorgan Stanley
Equal-Weight → Overweight$11.25+24.3%
Mar 05, 2025Downgrade
HSBC logoHHSBC Securities
Buy → Hold
Jan 10, 2025Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight
Jan 08, 2025Downgrade
BBernstein
Outperform → Mkt Perform
Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.
CEO & Executive DirectorMr. Brian James McNamara
CFO & DirectorMs. Dawn Amanda Allen
Chief Digital & Technology OfficerMs. Claire Dickson
Head of Investor RelationsMs. Joanne Russell
General CounselMr. Adrian Charles Morris